Media ReleasesLBT Innovations

View All LBT Innovations News

LBT Innovations - Quarterly Activities/Appendix 4C Cash Flow Report

Highlights for the Quarter

• Two APAS® Independence instruments sold in the UK to Health Services Laboratory
• US multi-laboratory purchasing opportunities - AdventHealth and Vizient
• EU Urine analysis modules released as evaluation modules ahead of regulatory clearance
• First published data demonstrating use of APAS® Independence for early culture plate reading
• Joanne Moss appointed as Chair-Elect as part of planned Board rejuvenation
• 30 June 2021 cash balance of $9.6 million

For more information, download the attached PDF.

Download this document

Are you a 708 sophisticated investor?

A sophisticated investor is defined under Section 708 of the Corporations Act (net assets of $2.5 million or annual incomes in excess of $250,000).

They are eligible to receive information regarding wholesale investment opportunities that are not available to regular or retail investors.

Please subscribe if you would like to be alerted to these types of opportunities.